Vilya Therapeutics: Editor’s Top Choice for Innovation
Quick Summary Nature Biotechnology annually selects companies with significant early-stage funding. Vilya Therapeutics is developing macrocycle drug candidates, which are a specific type of pharmaceutical innovation. Details about the company’s